LENZ Therapeutics, Inc. (LENZ)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 23
+0.02
+0.3839%
After Hours
$
+0.07 +1.3384% 5. 30
160.22M Market Cap
- P/E Ratio
4.12% Div Yield
603,982 Volume
- Eps
$ 5.21
Previous Close 
Want to track LENZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LENZ Earnings Reports FAQ
What is the earnings per share (EPS) for LENZ?
EPS data for LENZ is currently not available, as LENZ Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
LENZ Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
LENZ Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for LENZ Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LENZ at this time, as LENZ Therapeutics, Inc has no recent EPS data to calculate it.
